Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cognetivity Neurosciences Ltd (OP: CGNSF )

0.0058 +0.0029 (+100.00%)
Streaming Delayed Price Updated: 3:37 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 151,000
Open 0.0040
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0029
Today's Range 0.0040 - 0.0058
52wk Range 0.0011 - 0.1234
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help. 
Via Benzinga
UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round
A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. 
Via Benzinga

Performance

YTD
-57.35%
-57.35%
1 Month
+241.18%
+241.18%
3 Month
-67.78%
-67.78%
6 Month
-60.54%
-60.54%
1 Year
-95.23%
-95.23%

More News

Read More
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
Via Benzinga
Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression
Via Benzinga
Cognitive Assessment And Training Market Size Expected To Reach $15.65 Billion In 2028
Via FinancialNewsMedia
Exposures COVID-19
Cognetivity Neurosciences and InterSystems Partner to Fast-track Integration of Early Dementia Detection with Global Healthcare Systems
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.